{"schema_version":"1","generated_at":"2026-11-08T03:01:55.114Z","data_as_of":null,"url":"https://www.findmykol.com/kol/jesse-mcgreivy","json_url":"https://www.findmykol.com/kol/jesse-mcgreivy/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"jesse-mcgreivy","name":"Jesse McGreivy","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Kartos Therapeutics","institution_url":"https://www.findmykol.com/institution/kartos-therapeutics","city":"South San Francisco","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1659657500","openalex":"A5036657478"},"summary":"Jesse McGreivy is an Oncology physician affiliated with Kartos Therapeutics. OpenAlex indexes 54 publications with 6,428 citations (h-index 17).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":54,"cited_by_count":6428,"h_index":17,"latest_activity_year":2024,"source":"works"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Results from the Randomized, Multicenter, Global Phase 3 BOREAS Study: Navtemadlin Versus Best Available Therapy in JAK Inhibitor Relapsed/Refractory Myelofibrosis","year":2024,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2024-201642","status":"verified"},{"title":"Disease-Modifying Activity of Navtemadlin Correlates with Clinical Responses in a Randomized, Multicenter, Global Phase 3 Study (BOREAS) in JAK-Inhibitor Relapsed/Refractory Myelofibrosis","year":2024,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2024-205937","status":"verified"},{"title":"S210: AN OPEN-LABEL, GLOBAL, PHASE (PH) 1B/2 STUDY ADDING NAVTEMADLIN (NVTM) TO RUXOLITINIB (RUX) IN PATIENTS (PTS) WITH PRIMARY OR SECONDARY MYELOFIBROSIS (MF) WHO HAVE A SUBOPTIMAL RESPONSE TO RUX","year":2023,"journal":"HemaSphere","source_url":"https://doi.org/10.1097/01.hs9.0000967752.72578.ff","status":"verified"},{"title":"S214: DISEASE-MODIFYING ACTIVITY OF NAVTEMADLIN (NVTM) CORRELATED WITH SURVIVAL OUTCOMES IN JANUS KINASE INHIBITOR (JAKI) RELAPSED OR REFRACTORY (R/R) MYELOFIBROSIS (MF) PATIENTS (PTS)","year":2023,"journal":"HemaSphere","source_url":"https://doi.org/10.1097/01.hs9.0000967768.05521.ca","status":"verified"},{"title":"A Phase (Ph) 2 Study of TL-895, a Highly Selective, Novel Covalent BTK Inhibitor (BTKi), in Patients (pts) with Treatment-Naïve (TN) and Relapsed/Refractory (R/R) BTKi-Naïve Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)","year":2023,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2023-186517","status":"verified"}],"source":"works"},"contact":{"address_1":"1120 VETERANS BLVD","city":"South San Francisco","state":"CA","zip":"940801985","phone":"650-244-2634","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1659657500","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2011-10-24","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"}},"methodology_url":"https://www.findmykol.com/about#methodology"}